EUVIMEDEUVIMED entdecken
Fallbericht

Opioid-induced respiratory depression suspected of drug interaction in a prostate cancer patient: a case report

Hiroshi Hamada, Eisuke Suzuki, Mitsufumi Endo, Yukiko Mihara, Sayaka Iketani, Miki Ishida, Akime Miyasato, Kanako Miyazaki

Annals of Palliative Medicine · 2024

DOI: 10.21037/apm-23-581 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Palliative Medicine, 2024. Verfasst von Hiroshi Hamada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Antiemetics, Antineoplastic Agents, Prostatic Neoplasms, Respiratory Insufficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Many of the drugs used for the treatment and alleviation of symptoms in cancer patients are known to inhibit or induce cytochrome P450 (CYP). Therefore, it is important to pay attention to the drug interactions of opioid analgesics that are metabolized by CYPs, because for example when using oxycodone metabolized by CYP3A4, it is possible that the effect will be attenuated or enhanced by the concomitant use of drugs that induce or inhibit CYP3A4. Aprepitant, an antiemetic drug used in many patients receiving anticancer drugs, is known as a moderate competitive inhibitor of CYP3A4. We experienced a case of respiratory depression caused by opioids, which was suspected to be caused by a drug interaction with antiemetics especially aprepitant. CASE DESCRIPTION: The patient was a 72-year-old man. He had been treated with continuous oxycodone infusion for perianal pain associated with the rectal invasion of prostate cancer. No comorbidities other than renal dysfunction were observed. Oxycodone treatment was started at 48 mg/day, and was increased to 108 mg/day, and then the pain decreased. Once the pain was controlled, chemotherapy was planned. Antiemetics (dexamethasone, palonosetron, and aprepitant) were administered before anticancer drug administration. Approximately 3 hours after antiemetics administration and before the administration of the anticancer drugs, a ward nurse noticed that oversedation and respiratory depression had occurred. When the patient was called, he immediately woke up and was able to talk normally, so the anticancer drugs were administered as scheduled. About 2 hours after the nurse noticed oversedation, the attending physician reduced the dose of oxycodone infusion to 48 mg/day. After that, his drowsiness persisted, but his respiratory condition improved. Despite reducing the dose of oxycodone to less than half, the pain remained stable at numeric rating scale (NRS) 0-1, without the use of a rescue dose. The patient was discharged from the hospital 36 days after the administration of anticancer drugs, without any problems. CONCLUSIONS: The cause of respiratory depression in this case was thought to be a combination of factors, including drug interactions between oxycodone and antiemetics, and oxycodone accumulation due to renal dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsAntineoplastic AgentsProstatic NeoplasmsRespiratory InsufficiencyKidney DiseasesMaleHumansAgedAprepitantAnalgesics, OpioidOxycodoneCytochrome P-450 CYP3AMorpholinesDrug InteractionsPain

Stichwörter der Autor:innen

Drug interactionaprepitantcase reportoxycodone

Substanzen

AntiemeticsAprepitantAnalgesics, OpioidOxycodoneCytochrome P-450 CYP3AMorpholinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Palliative Medicine, Tokyo Medical University, Tokyo, Japan.

Zitieren

APA

Hamada, H., Suzuki, E., Endo, M., Mihara, Y., Iketani, S., Ishida, M., Miyasato, A., & Miyazaki, K. (2024). Opioid-induced respiratory depression suspected of drug interaction in a prostate cancer patient: a case report. Annals of Palliative Medicine. https://doi.org/10.21037/apm-23-581

Vancouver

Hamada H, Suzuki E, Endo M, Mihara Y, Iketani S, Ishida M, et al. Opioid-induced respiratory depression suspected of drug interaction in a prostate cancer patient: a case report. Annals of Palliative Medicine. 2024. doi:10.21037/apm-23-581

BibTeX
@article{Hamada2024,
  author = {Hamada, Hiroshi and Suzuki, Eisuke and Endo, Mitsufumi and Mihara, Yukiko and Iketani, Sayaka and Ishida, Miki and Miyasato, Akime and Miyazaki, Kanako},
  title = {Opioid-induced respiratory depression suspected of drug interaction in a prostate cancer patient: a case report},
  journal = {Annals of Palliative Medicine},
  year = {2024},
  doi = {10.21037/apm-23-581}
}
Kostenlos starten →